Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1990-04-02
1993-02-23
Stone, Jacqueline
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9464, 5142345, 5142338, 514321, 514322, 514367, 514375, 514394, 5483097, 5483101, A61K 37547, A61K 3754, A61K 3141
Patent
active
051888300
ABSTRACT:
Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
REFERENCES:
patent: 4873346 (1989-10-01), Anderson
patent: 4968494 (1990-11-01), Claremon et al.
patent: 5098707 (1992-03-01), Baldwin et al.
Abdel-Rahman et al., Chem. Abstracts, vol. 107:39674a (1987).
Simonov et al., Chem. Abstracts, vol. 81:25601g (1974).
Miura et al., Chem. Abstracts, vol. 92:32016a (1980).
Barreiro et al., Chem. Abstracts, vol. 98:198085w (1983).
Popov et al., Chem. Abstracts, vol. 74:76369a (1971).
Atkinson Joseph G.
Baldwin John J.
Claremon David A.
Friedman Paul A.
Remy David C.
Merck & Co. , Inc.
Robertson Alice O.
Speer Raymond M.
Stone Jacqueline
LandOfFree
Methods for thrombolytic therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for thrombolytic therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for thrombolytic therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203179